# How Future Surgery Will Benefit From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Related Measures Perspective From Italian Young Surgeon Society (SPIGC)

> **NCT05323851** · — · COMPLETED · sponsor: **University of Rome Tor Vergata** · enrollment: 581 (actual)

## Conditions studied

- COVID-19
- Health Behavior

## Interventions

- **BEHAVIORAL:** COVID-surg-SPIGC questionnaire

## Key facts

- **NCT ID:** NCT05323851
- **Lead sponsor:** University of Rome Tor Vergata
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-16
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 581 (ACTUAL)
- **Last updated:** 2022-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05323851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05323851, "How Future Surgery Will Benefit From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Related Measures Perspective From Italian Young Surgeon Society (SPIGC)". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05323851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*